Home » Topics » Regulatory

Regulatory
RSS

Santen files NDA for levofloxacin 1.5%

May 9, 2003

Effective use of transdermal buprenorphine in cancer and noncancer pain

May 9, 2003

Vioxx approved in Canada for use in rheumatoid arthritis

May 9, 2003

New Risperdal formulation launched

May 8, 2003

Extended-release ciprofloxacin in complicated urinary tract infections

May 8, 2003

Forest seeks label expansion for Lexapro to include panic disorder

May 6, 2003

FDA approves more convenient formulation of Viracept

May 6, 2003

FDA approves Aldurazyme for MPS I

May 5, 2003

Low-dose Premarin receives FDA approval

April 30, 2003

Nippon Boehringer Ingelheim and Sankyo intend to comarket Alesion

April 29, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...